Literature DB >> 24475383

Nephro and neurotoxicity of calcineurin inhibitors and mechanisms of rejections: A review on tacrolimus and cyclosporin in organ transplantation.

Zahra Tolou-Ghamari1.   

Abstract

CONTEXT: In the meadow of medical sciences substituting a diseased organ with a healthy one from another individual, dead or alive, to allow a human to stay alive could be consider as the most string event. In this article we review the history of transplantation, mechanisms of rejection, nephro-neurotoxicity of tacrolimus and cyclosporin in organ transplantations. EVIDENCE ACQUISITIONS: Directory of Open Access Journals (DOAJ), Google Scholar, Pubmed (NLM), LISTA (EBSCO) and Web of Science have been searched.
RESULTS: The first reference to the concept of organ transplantation and replacement for therapeutic purposes appears to be to Hua-To (136 to 208 A.D), who replaced diseased organs with healthy ones in patients under analgesia induced with a mixture of Indian hemp. In 1936, the first human renal transplant performed by Voronoy in Russia. The first liver transplant in humans was performed on March 1, 1963 by Starzl in Denver, USA. Medawar was the first to assert that rejection was an immunological response, with the inflammatory reaction due to lymphocyte infiltration. Consequently, rational immunosuppressive therapies could inhibit deleterious T-cell responses in an antigen specific manner.
CONCLUSIONS: Searching related to the history of organ transplantation from mythic to modern times suggests that, to prevent graft rejection, minimize nephro and neuro toxicity monitoring of immunosupressive concentrations could provide an invaluable and essential aid in adjusting dosage to ensure adequate immunosuppression.

Entities:  

Keywords:  Immunosuppression; Organ transplantation; Rejection; Toxicity

Year:  2012        PMID: 24475383      PMCID: PMC3886167          DOI: 10.5812/jnp.6

Source DB:  PubMed          Journal:  J Nephropathol        ISSN: 2251-8363


  44 in total

1.  In vitro pentamer formation as a biomarker of tacrolimus-related immunosuppressive activity after liver transplantation.

Authors:  Z Tolou-Ghamari; J Wendon; J M Tredger
Journal:  Clin Chem Lab Med       Date:  2000-11       Impact factor: 3.694

2.  Clinical monitoring of tacrolimus after liver transplantation using pentamer formation assay and microparticle enzyme immunoassay.

Authors:  Zahra Tolou-Ghamari; Abbas-Ali Palizban; John Michael Tredger
Journal:  Drugs R D       Date:  2004

3.  A new diagnostic algorithm for antibody-mediated microcirculation inflammation in kidney transplants.

Authors:  B Sis; G S Jhangri; J Riopel; J Chang; D G de Freitas; L Hidalgo; M Mengel; A Matas; P F Halloran
Journal:  Am J Transplant       Date:  2012-02-02       Impact factor: 8.086

Review 4.  Mechanisms and management of acute renal allograft rejection.

Authors:  M Suthanthiran; T B Strom
Journal:  Surg Clin North Am       Date:  1998-02       Impact factor: 2.741

5.  Liver transplantation.

Authors:  T E Starzl
Journal:  Gastroenterology       Date:  1997-01       Impact factor: 22.682

Review 6.  Graft rejection - endogenous or allogeneic?

Authors:  William R Critchley; James E Fildes
Journal:  Immunology       Date:  2012-06       Impact factor: 7.397

7.  T cell receptor antagonism mediated by interaction between T cell receptor junctional residues and peptide antigen analogues.

Authors:  D Ostrov; J Krieger; J Sidney; A Sette; P Concannon
Journal:  J Immunol       Date:  1993-05-15       Impact factor: 5.422

8.  State of the art of liver transplantation in the USA.

Authors:  M Kalayoglu; A M D'Alessandro; S J Knechtle; H W Sollinger; J D Pirsch; R M Hoffmann; F O Belzer
Journal:  Transplant Proc       Date:  1993-08       Impact factor: 1.066

Review 9.  New concepts to individualize calcineurin inhibitor therapy in renal allograft recipients.

Authors:  Claudia Sommerer; Thomas Giese; Stefan Meuer; Martin Zeier
Journal:  Saudi J Kidney Dis Transpl       Date:  2010-11

Review 10.  Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.

Authors:  D H Peters; A Fitton; G L Plosker; D Faulds
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

View more
  17 in total

1.  Non-monetary renal transplantation: An old issue and a new look from Holy Quran.

Authors:  Milad Baradaran-Ghahfarokhi
Journal:  J Nephropathol       Date:  2012-07-01

2.  Tacrolimus Decreases Cognitive Function by Impairing Hippocampal Synaptic Balance: a Possible Role of Klotho.

Authors:  Yoo Jin Shin; Sun Woo Lim; Sheng Cui; Eun Jeong Ko; Byung Ha Chung; Hong Lim Kim; Tae Ryong Riew; Mun Yong Lee; Chul Woo Yang
Journal:  Mol Neurobiol       Date:  2021-08-25       Impact factor: 5.590

3.  Erythropoietin ameliorates genetamicin-induced renal toxicity: A biochemical and histopathological study.

Authors:  Mahmoud Rafieian-Kopaei; Hamid Nasri; Mehdi Nematbakhsh; Azar Baradaran; Alaleh Gheissari; Hamid Rouhi; Seyed Mohammad Ahmadi Soleimani; Milad Baradaran-Ghahfarokhi; Fatemeh Ghaed-Amini; Mohammadreza Ardalan
Journal:  J Nephropathol       Date:  2012-07-01

4.  Significance of extracapillary proliferation in IgA-nephropathy patients with regard to clinical and histopathological variables.

Authors:  M Rafieian-Kopaei; A Baradaran; H Nasri
Journal:  Hippokratia       Date:  2013-07       Impact factor: 0.471

5.  Preventive and curative effects of ginger extract against histopathologic changes of gentamicin-induced tubular toxicity in rats.

Authors:  Hamid Nasri; Mehdi Nematbakhsh; Shamin Ghobadi; Roya Ansari; Najmeh Shahinfard; Mahmoud Rafieian-Kopaei
Journal:  Int J Prev Med       Date:  2013-03

6.  Ameliorative effects of metformin on renal histologic and biochemical alterations of gentamicin-induced renal toxicity in Wistar rats.

Authors:  Fatemeh Ghaed Amini; Mahmoud Rafieian-Kopaei; Mehdi Nematbakhsh; Azar Baradaran; Hamid Nasri
Journal:  J Res Med Sci       Date:  2012-07       Impact factor: 1.852

7.  Preliminary study related the incidence of methylprednisolone pulse therapy in patients visited multiple sclerosis clinic located at the isfahan kashani hospital.

Authors:  Zahra Tolou-Ghamari; Vahid Shaygannejad; Fereshteh Ashtari
Journal:  Int J Prev Med       Date:  2013-05

8.  What is the Real Fate of Vitamin D in Multiple Sclerosis?

Authors:  Vahid Shaygannejad; Zahra Tolou-Ghamari
Journal:  Int J Prev Med       Date:  2013-05

9.  Preliminarily Analysis of Carbamazepine (CBZ) C0 in Patients Visited Isfahan Epileptic Clinics.

Authors:  Zahra Tolou-Ghamari; Mohammad Reza Najafi; Jafar Mehavari Habibabadi; Mohmmad Zare
Journal:  Int J Prev Med       Date:  2013-05

10.  Association of proteinuria with various clinical findings and morphologic variables of oxford classification in immunoglobulin a nephropathy patients.

Authors:  Hamid Nasri; Yahya Madihi; Alireza Merrikhi; Allaleh Gheissari; Azar Baradaran; Soleiman Kheiri; Mahmoud Rafieian-Kopaei
Journal:  Int J Prev Med       Date:  2013-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.